Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus

Journal of Rheumatology

Volumn 36, Issue 10, 2009, Pages 2190-2194

  Soyfoo, Muhammad S ^a   Roth, Johannes ^b   Vogl, Thomas ^c   Pochet, Roland ^c   Decaux, Guy ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Inflammatory diseases; Neutrophils infection; S100A8 A9; Sledai; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; DOUBLE STRANDED DNA ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; LA ANTIBODY; METHYLPREDNISOLONE; RHEUMATOID FACTOR; RO ANTIBODY; SM ANTIBODY;

ADULT; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONCURRENT INFECTION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHAGOCYTES; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME;

EID: 70450179808     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081302     Document Type: Article

References (29)

1. Heizmann CW. The multifunctional S100 protein family. Methods Mol Biol 2002;172:69-80.
2. Kerkhoff C, Klempt M, Sorg C. Novel insights into structure and function of MRP8 and MRP 14. Biochim Biophys Acta 1998;1448:200-211.
3. Roth J, Vogl T, Sorg C, Sunderkötter C. Phagocyte specific S100 proteins: a novel group of pro inflammatory molecules. Trends Immunology 2003;24:155-158. (Pubitemid 36412096)
4. Nacken W, Roth J, Sorg C, Kerkhoff C. S100A8/A9: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 2003;60:569-580.
5. Wulfraat N. Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation. Ann Rheum Dis 2003;62:236-241.
6. Roth J, Burwinkel F, Van den Bos C, Goebeler M, Vollmer E, Sorg C. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation are translocated to plasma membrane and intermediate filaments in a calcium dependent manner. Blood 1993;82:1875-1883.
7. Frosch M, Strey A, Vogl T, et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000;43:628-637.
8. Goebeler M, Roth J, Burwinkel F, Vollmer E, Böcker W, Sorg C. Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection. Transplantation 1994;58:355-361.
9. Odink K, Cerletti N, Brüggen J, Clerc RG, Tarcsay L, Zwadlo G, et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987;330:80-82. (Pubitemid 17152420)
10. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994;35:669-674. (Pubitemid 24163796)
11. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, Van Zoelen MAD, et al. MRP8 and MRP14 are novel endogenous activators of toll-like receptor 4 promoting lethal endotoxin-induced shock. Nature Med 2007;13:1042-1049.
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-639.
14. Haga HJ, Brun JG, Berntzen HB, Cervera R, Khamashta M, Hughes GR. Calprotectin patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus 1993;2:47-50. (Pubitemid 23115237)
15. Spronk PE, Terborg EJ, Kallenberg CG. Patients with systemic lupus erythematosus and jaccoud arthropathy. A clinical subset with increased C-reactive protein response? Ann Rheum Dis 1992;51:358-361.
16. Becker G, Waldburger M, Hughes G. Value of C-reactive protein levels in the investigation of fever in SLE. Ann Rheum Dis 1980;39:50-52.
17. Terborg EJ, Horst G, Limburg PC, Van Rijswijk MH, Kallenberg CGM. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus. A prospective, longitudinal study. J Rheumatol 1990;17:1642-1648.
18. Pepys MB, Lanham JG, Debeer FC. C-reactive protein in SLE. Clin Rheum Dis 1982;8:91-103.
19. Midleton GD, McFarlin JE, Sipe JD, Lipsky PE. C-reactive protein and systemic lupus erythematosus: elevation does not predict infection [abstract]. Arthritis Rheum 1994;37 Suppl:S321.
20. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993;91:1351-1357.
21. Sjowall C, Bengtsson AA, Sturfelt G, Skogh T. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Res Ther 2004;6:R87-94.
22. Sturfelt G, Sjöholm AG. Complement components, complement activation, and acute phase response in systemic lupus erythematosus. Int Arch Allergy Appl Immunol 1984;75:75-83. (Pubitemid 14094447)
23. Suh H, Chun HY, Ye YM, Park HS. Unresponsiveness of C-reactive protein in non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6. Clin Immunol 2006;119:291-296.
24. Foell D, Wittkowski H, Roth J. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat Clin Pract Rheumatol 2007;3:382-390.
25. Sampson B, Fagerhol MK, Sunderkötter C, Golden BE, Richmond P, Klein N, et al. Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism. Lancet 2002;360:1742-1745. (Pubitemid 35447905)
26. Van Lent PLEM, Grevers L, Blom AB, Sloetjes A, Mort JS, Vogl T, et al. Myeloid related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis 2008;67:1750-1758.
27. Suh CH, Jeong YS, Park HC, Lee CH, Lee J, Song CH, et al. Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus. Clin Exp Rheumatol 2001;19:191-194. (Pubitemid 32372457)
28. Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997;50:113-123. (Pubitemid 27454995)
29. Miniter MF, Stollar BD, Agnello V. Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus. Arthritis Rheum 1979;22:959-968. (Pubitemid 10165105)